WBR0247: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (refreshing WBR questions)
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor= {{Rim}} (Reviewed by William J Gibson and  {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pathology
|MainCategory=Pathology
Line 8: Line 8:
|MainCategory=Pathology
|MainCategory=Pathology
|SubCategory=Gastrointestinal
|SubCategory=Gastrointestinal
|MainCategory=Pathology
|MainCategory=Pathology
|MainCategory=Pathology
|MainCategory=Pathology
|MainCategory=Pathology
Line 20: Line 21:
|MainCategory=Pathology
|MainCategory=Pathology
|SubCategory=Gastrointestinal
|SubCategory=Gastrointestinal
|Prompt=A 45 year old male patient, known to have a positive family history of colon cancer in his father at the age of 55, presents to his general practitioner for an annual checkup.  His physician informs him that it is recommended that he undergoes a screening colonoscopy 10 years prior to the age his father had colon cancer. The patient asks the physisican about the etiology of colon cancer.  His physician answers that most cases of colon cancer are sporadic while some are familial and they are related to mutations in some genes. Mutation in which of the following genes is associated with familial colon cancer?
|Prompt=A 45-year-old man presents to the physician's office for an annual check-up. His father was diagnosed with colon cancer at the age of 55, and the physician now recommends that the patient undergoes a screening colonoscopy. The physician then explains that the majority of colon cancer cases are due to sporadic development, but familial forms are also present. A mutation in which gene is most likely associated with familial colon cancer?
|Explanation=Familial adenomatosis polyposis (FAP) is an inherited condition with an autosomal dominant mutation of the APC gene on chromosome 5q. It is characterized by early excessive growth of polyps that progress to colon cancer in 100% of affected individuals. The pathogenesis of FAP has been extensively studied.  Tumorogenesis of FAP is based on a two-hit hypothesis that will transform the normal mucosa by an “adenoma-to-carcinoma” sequence.
|Explanation=[[Familial adenomatosis polyposis]] (FAP) is an autosomal dominant genetic disease caused by a mutation in the ''APC'' gene on chromosome 5q. FAP is often characterized by the development of hundreds of polyps that ultimately progress to colon cancer in affected individuals. The genetic and clinical evolution of colon cancer proceeds through a well characterized adenoma-to-carcinoma” sequence. In normal individuals, two functioning copies of the ''APC'' gene exist in all cells. To bi-allelically inactivate the ''APC'' gene, both copies must be mutated or deleted. However, in individuals with FAP, one copy of the gene has already been inactivated since birth, thereby shortening the somatic process of bi-allelic inactivation to one "hit". Loss-of-function of the ''APC'' gene leads to hyperactivation of the beta-catenin pathway, a crucial signaling pathway that governs growth control in the colonic epithelium. Therefore, loss of ''APC'' leads to the formation of small polyps. However, inactivation of ''APC'' alone is insufficient to cause carcinoma. Secondary oncogenic genetic alterations must occur, the most common of which is mutation of a single amino acid in the ''KRAS'' gene. ''KRAS'' mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. Further loss of the tumor suppressor genes ''TP53'' and ''SMAD4'' lead to the transformation of the tumor from an adenoma into a carcinoma. The cooperation of the ''APC'', ''KRAS'', and ''TP53'' genes in colon cancer is the best documented instance of "oncogene cooperation" in cancer biology.
The first step of the two-hit hypothesis involves a mutation of the tumor suppressor gene APC. Loss of APC will cause a reduction of intercellular adhesion leading to the progression to a small polyp. Then, a mutation of K-ras, a GTPase, causes an increased uncontrolled intracellular signal transduction stimulating cell growth causing an increase in the polyp size. Further loss of the tumor suppressor genes p53 and DCC attribute to the malignant transformation from an adenoma into a carcinoma.
|AnswerA=''C-KIT''
 
|AnswerAExp=''[[C-KIT]]'' oncogene is associated with gastrointestinal stromal tumors ([[GIST]]).
Educational objective: Mutation in [[Ras|K-ras]] oncogene is implicated in [[colon cancer]].
|AnswerB=''RET''
 
|AnswerBExp=The ''[[Ret gene|RET oncogene]]'' is associated with [[multiple endocrine neoplasia]] (MEN) syndromes 2A and 2B
|AnswerA=C-kit
|AnswerC=''BRAF''
|AnswerAExp=[[C-kit]] oncogene is associated with [[GIST]].
|AnswerCExp=The ''BRAF'' oncogene is associated with melanoma.
|AnswerB=Ret
|AnswerD=''KRAS''
|AnswerBExp=[[Ret gene|Ret oncogene]] is associated with [[MEN|MEN syndrome]] type IIa and IIb.
|AnswerDExp=The ''[[KRAS]]'' oncogene is associated with colorectal cancer.
|AnswerC=Abl
|AnswerE=''C-MYC''
|AnswerCExp=[[Abl gene|Abl oncogene]] is associated with CML.
|AnswerEExp=The ''[[C-MYC]]'' oncogene is associated with [[Burkitt's lymphoma]].
|AnswerD=Ras
|EducationalObjectives=Mutations in [[Ras|''KRAS'']] oncogene are implicated in the tumorigenesis of [[colon cancer]]. ''KRAS'' mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium.
|AnswerDExp=[[Ras]] oncogene is associated with colon carcinoma.
|References=Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67.<br>
|AnswerE=C-myc
First Aid 2014 page 359 <br>
|AnswerEExp=C-myc is associated with [[Burkitt's lymphoma]].
|RightAnswer=D
|RightAnswer=D
|Approved=No
|WBRKeyword=Cancer, Colon cancer, Polyp, FAP, Familial adenomatous polyposis, CRC, Colorectal cancer
|Approved=Yes
}}
}}

Latest revision as of 23:54, 27 October 2020

 
Author [[PageAuthor::Rim Halaby, M.D. [1] (Reviewed by William J Gibson and Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pathology
Sub Category SubCategory::Gastrointestinal
Prompt [[Prompt::A 45-year-old man presents to the physician's office for an annual check-up. His father was diagnosed with colon cancer at the age of 55, and the physician now recommends that the patient undergoes a screening colonoscopy. The physician then explains that the majority of colon cancer cases are due to sporadic development, but familial forms are also present. A mutation in which gene is most likely associated with familial colon cancer?]]
Answer A AnswerA::''C-KIT''
Answer A Explanation [[AnswerAExp::C-KIT oncogene is associated with gastrointestinal stromal tumors (GIST).]]
Answer B AnswerB::''RET''
Answer B Explanation [[AnswerBExp::The RET oncogene is associated with multiple endocrine neoplasia (MEN) syndromes 2A and 2B]]
Answer C AnswerC::''BRAF''
Answer C Explanation AnswerCExp::The ''BRAF'' oncogene is associated with melanoma.
Answer D AnswerD::''KRAS''
Answer D Explanation [[AnswerDExp::The KRAS oncogene is associated with colorectal cancer.]]
Answer E AnswerE::''C-MYC''
Answer E Explanation [[AnswerEExp::The C-MYC oncogene is associated with Burkitt's lymphoma.]]
Right Answer RightAnswer::D
Explanation [[Explanation::Familial adenomatosis polyposis (FAP) is an autosomal dominant genetic disease caused by a mutation in the APC gene on chromosome 5q. FAP is often characterized by the development of hundreds of polyps that ultimately progress to colon cancer in affected individuals. The genetic and clinical evolution of colon cancer proceeds through a well characterized adenoma-to-carcinoma” sequence. In normal individuals, two functioning copies of the APC gene exist in all cells. To bi-allelically inactivate the APC gene, both copies must be mutated or deleted. However, in individuals with FAP, one copy of the gene has already been inactivated since birth, thereby shortening the somatic process of bi-allelic inactivation to one "hit". Loss-of-function of the APC gene leads to hyperactivation of the beta-catenin pathway, a crucial signaling pathway that governs growth control in the colonic epithelium. Therefore, loss of APC leads to the formation of small polyps. However, inactivation of APC alone is insufficient to cause carcinoma. Secondary oncogenic genetic alterations must occur, the most common of which is mutation of a single amino acid in the KRAS gene. KRAS mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. Further loss of the tumor suppressor genes TP53 and SMAD4 lead to the transformation of the tumor from an adenoma into a carcinoma. The cooperation of the APC, KRAS, and TP53 genes in colon cancer is the best documented instance of "oncogene cooperation" in cancer biology.

Educational Objective: Mutations in KRAS oncogene are implicated in the tumorigenesis of colon cancer. KRAS mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium.
References: Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67.
First Aid 2014 page 359
]]

Approved Approved::Yes
Keyword WBRKeyword::Cancer, WBRKeyword::Colon cancer, WBRKeyword::Polyp, WBRKeyword::FAP, WBRKeyword::Familial adenomatous polyposis, WBRKeyword::CRC, WBRKeyword::Colorectal cancer
Linked Question Linked::
Order in Linked Questions LinkedOrder::